According to Cocrystal Pharma 's latest financial reports the company's current EPS (TTM) is -$2.29. In 2022 the company made an earnings per share (EPS) of -$4.76 a decrease over its 2021 EPS that were of -$0.16.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.29 | -51.89% |
2022 | -$4.76 | 2875% |
2021 | -$0.16 | -92.59% |
2020 | -$2.16 | -88.08% |
2019 | -$18.12 | -13.71% |
2018 | -$21.00 | 5733.33% |
2017 | -$0.36 | -99.12% |
2016 | -$40.73 | 36.5% |
2015 | -$29.84 | 340.44% |
2014 | -$6.77 | -64.42% |
2013 | -$19.04 | -60.13% |
2012 | -$47.75 | 58.94% |
2011 | -$30.04 | 943.17% |
2010 | -$2.88 | |
2009 | N/A | -100% |
2008 | -$0.36 |